Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy

Detalles Bibliográficos
Autores principales: de Jong, Wesley, Aerts, Joeri, Allard, Sabine, Brander, Christian, Buyze, Jozefien, Florence, Eric, van Gorp, Eric, Vanham, Guido, Leal, Lorna, Mothe, Beatriz, Thielemans, Kris, Plana, Montse, Garcia, Félipe, Gruters, Rob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909442/
https://www.ncbi.nlm.nih.gov/pubmed/31836017
http://dx.doi.org/10.1186/s13063-019-3940-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909442/
https://www.ncbi.nlm.nih.gov/pubmed/31836017
http://dx.doi.org/10.1186/s13063-019-3940-0

Ejemplares similares